Cytogenetic and immunologic technologies for radiation dose assessment

dc.contributor.author	CORETCHI, L.
dc.date.accessioned	2019-10-23T13:49:10Z
dc.date.available	2019-10-23T13:49:10Z
dc.date.issued	2016
dc.identifier.citation	CORETCHI, L. Cytogenetic and immunologic technologies for radiation dose assessment. In: Health Technology Management. Book of abstracts: proc. of the 3rd intern. conf., October 6-17, 2016. Chişinău, 2016, p. 93. ISBN 978-9975-51-774-4	en_US
dc.identifier.isbn	978-9975-51-774-4
dc.identifier.uri	http://repository.utm.md/handle/5014/5135
dc.description	Abstract	en_US
dc.description.abstract	Cytogenetic dosimetry is recognized as a valuable dose assessment method which fills a gap in dosimetric technology, particularly when there are difficulties in interpreting the data. In cases where there is reason to believe that persons not wearing dosimeters have been exposed to radiation, in cases of claims for compensation for radiation injures that are not supported by unequivocal dosimetric evidence, or in cases of exposure over an individual’s working lifetime.	en_US
dc.language.iso	en	en_US
dc.publisher	Tehnica UTM	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	cytogenetic dosimetry	en_US
dc.subject	Chernobyl nuclear accident	en_US
dc.title	Cytogenetic and immunologic technologies for radiation dose assessment	en_US
dc.type	Article	en_US